China Universal Asset Management Co., Ltd. Bluebird Bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 36,580 shares of BLUE stock, worth $33,653. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,580
Previous 36,580
-0.0%
Holding current value
$33,653
Previous $47,000
2.13%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BLUE
# of Institutions
173Shares Held
104MCall Options Held
827KPut Options Held
1.23M-
Black Rock Inc. New York, NY15.2MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$9.66 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA7.71MShares$7.09 Million0.35% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$5.88 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.24MShares$5.74 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $71M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...